Guidance
Evidence-based recommendations on Ambu aScope4 Broncho for use in unexpected difficult airways.
In June 2019, we updated the guidance to refer to the latest version of the device, which has been modified but works in the same way as earlier versions. Details of the modifications are explained in the review decision. The guidance also includes revised cost-saving estimates. New evidence and updated costs identified during the guidance review are denoted as [2019].
Is this guidance up to date?
In January 2022, NICE started the review of this guidance. To register as a stakeholder, please contact us at medtech@nice.org.uk.
Guidance development process
How we develop NICE medical technologies guidance
NICE medical technologies guidance addresses specific technologies notified to NICE by sponsors. The ‘case for adoption’ is based on the claimed advantages of introducing the specific technology compared with current management of the condition. This case is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.